R1 RCM (R1 RCM) Cash And Cash Equivalents : $178 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is R1 RCM Cash And Cash Equivalents?

R1 RCM's quarterly cash and cash equivalents increased from Sep. 2023 ($164.90 Mil) to Dec. 2023 ($173.60 Mil) and increased from Dec. 2023 ($173.60 Mil) to Mar. 2024 ($178.00 Mil).

R1 RCM's annual cash and cash equivalents declined from Dec. 2021 ($130.10 Mil) to Dec. 2022 ($110.10 Mil) but then increased from Dec. 2022 ($110.10 Mil) to Dec. 2023 ($173.60 Mil).

R1 RCM Cash And Cash Equivalents Historical Data

The historical data trend for R1 RCM's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM Cash And Cash Equivalents Chart

R1 RCM Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

92.00

173.80

130.10

110.10

173.60

R1 RCM Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															104.20	123.10	164.90	173.60	178.00

R1 RCM Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

R1 RCM (NAS:RCM) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

R1 RCM Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of R1 RCM's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

R1 RCM (R1 RCM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (NAS:RCM) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

6HL:Germany 6HL0:Germany

Address

434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123

Website

https://www.r1rcm.com

R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.

Executives

Dominic Nakis	director	433 W ASCENSION WAY, SUITE 200, MURRAY UT 84123
Henneman John B Iii	director	311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Evans Richard B. Jr.	officer: Principal Accounting Officer	C/O ACCRETIVE HEALTH, INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
John M. Sparby	officer: See Remarks	C/O R1 RCM INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Lee Rivas	officer: President	C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Kyle Hicok	officer: Chief Commercial Officer	434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Jennifer D. Williams	officer: Chief Financial Officer	434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Janie Wade	director	C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Tcp-asc Achi Series Lllp	director, 10 percent owner	65 E 55TH ST 27TH FLOOR, TOWERBROOK CAPITAL PARTNERS L.P., NEW YORK NY 10022
Joseph Gerard Flanagan	director, officer: Chief Executive Officer	C/O NORTEL NETWORKS CORPORATION, 195 THE WEST MALL, TORONTO A6 M9C 5K1
Brian K. Dean	director	R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Gary Steven Long	officer: See Remarks	7050 BRIXTON PLACE, SUWANEE GA 30024
Michael C. Feiner	director	1166 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036
Matthew S. Holt	director	C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019
Bradford Kyle Armbrester	director	311 ARSENAL STREET, WATERTOWN MA 02472